Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
Urogynecology (Philadelphia, Pa.)
|
January 27, 2026
Safety and Feasibility of Concomitant Urogynecologic and Gynecologic Oncology Surgical Procedures
Kyle Wohlrab, Katina Robison, David D Rahn, et al.
Gland Surgery
|
July 23, 2019
Choosing high-risk screening <i>vs.</i> surgery and the effect of treatment modality on anxiety and breast-specific sensuality in BRCA mutation carriers
Kristin E Rojas, Elizabeth Butler, Julie Gutierrez, et al.
Gynecologic Oncology
|
January 28, 2026
Safety and feasibility of concomitant urogynecologic and gynecologic oncology surgical procedures
Kyle Wohlrab, Katina Robison, David D Rahn, et al.
Gynecologic Oncology
|
July 7, 2015
Assessing the prognostic role of ATR mutation in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study
Israel Zighelboim, Shamshad Ali, Heather A Lankes, et al.
Journal of Genetic Counseling
|
April 27, 2021
Family planning in carriers of BRCA1 and BRCA2 pathogenic variants
Jessica M Haddad, Katina Robison, Lindsey Beffa, et al.
Menopause (New York, N.Y.)
|
May 16, 2023
Barriers to hormone therapy following prophylactic bilateral salpingo-oophorectomy in BRCA1/2 mutation carriers
Jessica B DiSilvestro, Jessica Haddad, Katina Robison, et al.
Journal of Women'S Health (2002)
|
March 15, 2024
Ovarian Cancer Risk-Reduction and Screening in <i>BRCA1/2</i> Mutation Carriers
Jessica B DiSilvestro, Jessica Haddad, Katina Robison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 6, 2018
Adjuvant Gemcitabine Plus Docetaxel Followed by Doxorubicin Versus Observation for High-Grade Uterine Leiomyosarcoma: A Phase III NRG Oncology/Gynecologic Oncology Group Study
Martee L Hensley, Danielle Enserro, Helen Hatcher, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 2, 2020
Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study
Dana Chase, Helen Q Huang, Bradley J Monk, et al.
Obstetrics and Gynecology
|
March 10, 2023
Endometrial Cancer Surgery With or Without Concomitant Stress Urinary Incontinence Surgery
Katina Robison, Kyle Wohlrab, Chanelle J Howe, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
Urogynecology (Philadelphia, Pa.)
|
January 27, 2026
Safety and Feasibility of Concomitant Urogynecologic and Gynecologic Oncology Surgical Procedures
Kyle Wohlrab, Katina Robison, David D Rahn, et al.
Gland Surgery
|
July 23, 2019
Choosing high-risk screening <i>vs.</i> surgery and the effect of treatment modality on anxiety and breast-specific sensuality in BRCA mutation carriers
Kristin E Rojas, Elizabeth Butler, Julie Gutierrez, et al.
Gynecologic Oncology
|
January 28, 2026
Safety and feasibility of concomitant urogynecologic and gynecologic oncology surgical procedures
Kyle Wohlrab, Katina Robison, David D Rahn, et al.
Gynecologic Oncology
|
July 7, 2015
Assessing the prognostic role of ATR mutation in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study
Israel Zighelboim, Shamshad Ali, Heather A Lankes, et al.
Journal of Genetic Counseling
|
April 27, 2021
Family planning in carriers of BRCA1 and BRCA2 pathogenic variants
Jessica M Haddad, Katina Robison, Lindsey Beffa, et al.
Menopause (New York, N.Y.)
|
May 16, 2023
Barriers to hormone therapy following prophylactic bilateral salpingo-oophorectomy in BRCA1/2 mutation carriers
Jessica B DiSilvestro, Jessica Haddad, Katina Robison, et al.
Journal of Women'S Health (2002)
|
March 15, 2024
Ovarian Cancer Risk-Reduction and Screening in <i>BRCA1/2</i> Mutation Carriers
Jessica B DiSilvestro, Jessica Haddad, Katina Robison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 6, 2018
Adjuvant Gemcitabine Plus Docetaxel Followed by Doxorubicin Versus Observation for High-Grade Uterine Leiomyosarcoma: A Phase III NRG Oncology/Gynecologic Oncology Group Study
Martee L Hensley, Danielle Enserro, Helen Hatcher, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 2, 2020
Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study
Dana Chase, Helen Q Huang, Bradley J Monk, et al.
Obstetrics and Gynecology
|
March 10, 2023
Endometrial Cancer Surgery With or Without Concomitant Stress Urinary Incontinence Surgery
Katina Robison, Kyle Wohlrab, Chanelle J Howe, et al.
Page
of 7